NONOF - Eli Lilly Q4 results to highlight Zepbound uptake
2024-02-05 12:38:30 ET
More on Eli Lilly
- Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value
- Biotech And Pharma Diversification Pays Off
- Eli Lilly: The Cupboard Is Fully Stocked
- Eli Lilly sees highest intraday trade since November ahead of earnings
- U.S. govt. opens bids in Medicare drug price negotiations